EAGLE ASSET MANAGEMENT INC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$13,367,126
-22.4%
497,474
+3.0%
0.08%
-17.7%
Q2 2023$17,222,888
+63.0%
482,975
+16.1%
0.10%
+54.8%
Q1 2023$10,566,000
-39.7%
416,005
-8.6%
0.06%
-42.1%
Q4 2022$17,521,000
+16.6%
454,994
+0.1%
0.11%
+9.2%
Q3 2022$15,028,000
-15.6%
454,717
-10.0%
0.10%
-12.5%
Q2 2022$17,796,000
-27.7%
505,433
-5.6%
0.11%
-11.1%
Q1 2022$24,631,000
-28.8%
535,586
+4.2%
0.13%
-17.1%
Q4 2021$34,606,000
+7.3%
513,838
-0.6%
0.15%
+4.1%
Q3 2021$32,263,000
-32.7%
516,789
-10.7%
0.15%
-29.1%
Q2 2021$47,933,000
+19.7%
578,770
-3.0%
0.21%
+16.4%
Q1 2021$40,035,000
-22.4%
596,918
-11.2%
0.18%
-39.2%
Q4 2020$51,570,000
+58.9%
672,104
-10.1%
0.29%
+74.3%
Q3 2020$32,461,000
+7.6%
747,623
+5.6%
0.17%
-2.9%
Q2 2020$30,166,000
+48.1%
708,137
+0.0%
0.17%
+35.4%
Q1 2020$20,365,000
-54.4%
707,867
+0.5%
0.13%
-40.9%
Q4 2019$44,658,000704,0640.22%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders